News
·
By Deana Stankovic
Summary
We're delighted to announce our event ‘From Evidence to Authorisation: Enabling Medicines, Medical Devices and AI Innovation in Scotland’
Join colleagues from across Scotland's innovation ecosystem for an opportunity to engage with the Medicines and Healthcare products Regulatory Agency (MHRA), share insights, and strengthen collaboration across the healthcare innovation landscape.
Topics to be covered include:
The evolving UK regulatory framework for medical devices.
Combined clinical trials of investigational medicinal products and clinical investigations of medical devices (CTIMP/CIMD studies).
Post-market surveillance (PMS) and ongoing safety and performance monitoring of medical devices
Innovative regulatory pathways for medicines.
The session will provide practical insight into the processes that help bring new medicines, medical devices and AI-enabled technologies safely into healthcare. A rare opportunity to directly engage with the MHRA, for colleagues within the innovation ecosystem in Scotland.
At the hub we strongly believe that by bringing together innovators, researchers, clinicians, industry and regulators, we can create a platform for collaboration that accelerates the adoption of healthcare innovations. Innovations with a clear focus on patient outcomes and staff experience within Scotland, and beyond.
We look forward to welcoming you next month!
